Abstract
Extraskeletal myxoid chondrosarcoma is a rare tumor with less than 100 cases reported in the literature [1]. The prevalence of anti-Hu positive myxoid chondrosarcoma-associated paraneoplastic subacute cerebellar degeneration is exceedingly rare. We present a report of a patient with confirmed myxoid chondrosarcoma-associated paraneoplastic subacute cerebellar degeneration, who exhibited marked improvement within 1 week of receiving chemotherapy, intravenous immunoglobulin (IVIG), and hydrocortisone treatment.
This is a preview of subscription content, log in via an institution to check access.
References
Chow WA (2007) Update on chondrosarcomas. Curr Opin Oncol 19:371–376
Molinuevo J, Graus F, Serrano C et al (2004) Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy. Ann Neurol 44:976–980
Verschuuren JP, Twinjstra J, De Baets M (1994) Hu antigens and anti-Hu antibodies in a patient with myxoid chondrosarcoma. Neurology 44:1551–1552
Dalmau J, Posner JB (1994) Neurologic paraneoplastic antibodies (anti-Yo, anti-Hu, anti-Ri): the case for a nomenclature based on antibody and antigen specificity. Neurology 44:2241–2246
Dalmau J, Gonzalez RG, Lerwill MF (2007) Case 4-2007: a 56-year-old woman with rapidly progressive vertigo and ataxia. N Engl J Med 356:612–620
Dalmau J, Graus F, Rosenblum MK et al (1992) Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuropathy: a clinical study of 71 patients. Medicine 71:59–72
Darnell RB, Posner JB (2003) Paraneoplastic syndromes involving the nervous system. N Engl J Med 349:1543–1554
Rosenblum MK (1999) Paraneoplasia and autoimmunologic injury of the nervous system: the anti-Hu syndrome. Brain Pathol 3:199–212
Furneaux HM, Reich L, Posner JB (1990) Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 40:1085–1091
Smitt PS, Kinoshita A, De Leeuw B et al (2000) Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med 342:21–27
Vedeler CA, Antoine JC, Giometto B et al (2006) Paraneoplastic neurological syndrome euronetwork. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol 11:682–690
Byrne T, Mason WP, Posner JB et al (1997) Spontaneous neurological improvement in anti-Hu associated encephalomyelitis. J Neurol Neurosurg Psychiatry 62:276–278
Dalmau J, Furneaux HM, Gralla RJ et al (1990) Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer—a quantitative Western blot analysis. Ann Neurol 27:544–552
Storstein A, Vedeler CA (2007) Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects. Adv Clin Chem 44:143–185
Graus F, Dalmou J, Reñé R et al (1997) Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 15:2866–2872
Keime-Guibert F, Graus F, Fleury A et al (2000) Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 68:479–482
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Hoosien, M., Vredenburgh, J., Lanfranco, J. et al. A myxoid chondrosarcoma associated with an anti-Hu-positive paraneoplastic encephalomyelitis. J Neurooncol 101, 135–139 (2011). https://doi.org/10.1007/s11060-010-0216-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-010-0216-7